Immune Thrombocytopenia (ITP)

Immune Thrombocytopenia(ITP) is an autoimmune disorder in which the body's immune system mistakenly attacks and destroys its own platelets, resulting in a reduced platelet count. Platelets are essential blood components that help stop bleeding by forming clots. When platelet levels fall significantly, individuals become more susceptible to bruising, prolonged bleeding, and tiny red or purple spots on the skin known as petechiae. ITP can occur in both children and adults. In children, it often develops after a viral infection and may resolve spontaneously, whereas adults are more likely to experience a chronic form of the condition.

The exact cause of ITP is not always known, although immune dysfunction is the primary mechanism. Diagnosis involves blood tests to confirm low platelet counts while excluding other causes of thrombocytopenia. Bone marrow examination may be recommended in selected cases.

Treatment depends on the severity of symptoms and platelet levels. Mild cases may only require regular monitoring, while symptomatic patients may receive corticosteroids, intravenous immunoglobulin (IVIG), or medications that stimulate platelet production. In severe or persistent cases, immunosuppressive therapies or surgical removal of the spleen may be considered. With timely diagnosis, appropriate treatment, and regular follow-up, many people with ITP can successfully manage the condition and maintain a healthy, active lifestyle.